120
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A small cell lung cancer genome reports complex tobacco exposure signatures

      research-article
      (1) , (1) , (1) , (2) , (1) , (3) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (2) , (4) , (5) , (5) , (5) , (5) , (5) , (6) , (6) , (3) , (4) , (5) , (1) , (7) , (1) , (1) , (8)
      Nature

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          SUMMARY

          Cancer is driven by mutation. Worldwide, tobacco smoking is the major lifestyle exposure that causes cancer, exerting carcinogenicity through >60 chemicals that bind and mutate DNA. Using massively parallel sequencing technology, we sequenced a small cell lung cancer cell line, NCI-H209, to explore the mutational burden associated with tobacco smoking. 22,910 somatic substitutions were identified, including 132 in coding exons. Multiple mutation signatures testify to the cocktail of carcinogens in tobacco smoke and their proclivities for particular bases and surrounding sequence context. Effects of transcription-coupled repair and a second, more general expression-linked repair pathway were evident. We identified a tandem duplication that duplicates exons 3-8 of CHD7 in-frame, and another two lines carrying PVT1-CHD7 fusion genes, suggesting that CHD7 may be recurrently rearranged in this disease. These findings illustrate the potential for next-generation sequencing to provide unprecedented insights into mutational processes, cellular repair pathways and gene networks associated with cancer.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          Patterns of somatic mutation in human cancer genomes.

          Cancers arise owing to mutations in a subset of genes that confer growth advantage. The availability of the human genome sequence led us to propose that systematic resequencing of cancer genomes for mutations would lead to the discovery of many additional cancer genes. Here we report more than 1,000 somatic mutations found in 274 megabases (Mb) of DNA corresponding to the coding exons of 518 protein kinase genes in 210 diverse human cancers. There was substantial variation in the number and pattern of mutations in individual cancers reflecting different exposures, DNA repair defects and cellular origins. Most somatic mutations are likely to be 'passengers' that do not contribute to oncogenesis. However, there was evidence for 'driver' mutations contributing to the development of the cancers studied in approximately 120 genes. Systematic sequencing of cancer genomes therefore reveals the evolutionary diversity of cancers and implicates a larger repertoire of cancer genes than previously anticipated.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            DNA methylation profiling of human chromosomes 6, 20 and 22

            DNA methylation constitutes the most stable type of epigenetic modifications modulating the transcriptional plasticity of mammalian genomes. Using bisulfite DNA sequencing, we report high-resolution methylation reference profiles of human chromosomes 6, 20 and 22, providing a resource of about 1.9 million CpG methylation values derived from 12 different tissues. Analysis of 6 annotation categories, revealed evolutionary conserved regions to be the predominant sites for differential DNA methylation and a core region surrounding the transcriptional start site as informative surrogate for promoter methylation. We find 17% of the 873 analyzed genes differentially methylated in their 5′-untranslated regions (5′-UTR) and about one third of the differentially methylated 5′-UTRs to be inversely correlated with transcription. While our study was controlled for factors reported to affect DNA methylation such as sex and age, we did not find any significant attributable effects. Our data suggest DNA methylation to be ontogenetically more stable than previously thought.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A faster circular binary segmentation algorithm for the analysis of array CGH data.

              Array CGH technologies enable the simultaneous measurement of DNA copy number for thousands of sites on a genome. We developed the circular binary segmentation (CBS) algorithm to divide the genome into regions of equal copy number. The algorithm tests for change-points using a maximal t-statistic with a permutation reference distribution to obtain the corresponding P-value. The number of computations required for the maximal test statistic is O(N2), where N is the number of markers. This makes the full permutation approach computationally prohibitive for the newer arrays that contain tens of thousands markers and highlights the need for a faster algorithm. We present a hybrid approach to obtain the P-value of the test statistic in linear time. We also introduce a rule for stopping early when there is strong evidence for the presence of a change. We show through simulations that the hybrid approach provides a substantial gain in speed with only a negligible loss in accuracy and that the stopping rule further increases speed. We also present the analyses of array CGH data from breast cancer cell lines to show the impact of the new approaches on the analysis of real data. An R version of the CBS algorithm has been implemented in the "DNAcopy" package of the Bioconductor project. The proposed hybrid method for the P-value is available in version 1.2.1 or higher and the stopping rule for declaring a change early is available in version 1.5.1 or higher.
                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                Nature
                0028-0836
                1476-4687
                15 December 2009
                16 December 2009
                14 January 2010
                14 July 2010
                : 463
                : 7278
                : 184-190
                Affiliations
                [(1) ] Wellcome Trust Sanger Institute, Hinxton, UK.
                [(2) ] Applied Biosystems, Warrington, UK.
                [(3) ] European Bioinformatics Institute, Hinxton, UK.
                [(4) ] Life Technologies, Foster City, California, USA.
                [(5) ] Life Technologies, Beverley, Massachusetts, USA.
                [(6) ] University of Texas Southwestern Medical Center, Dallas, Texas, USA.
                [(7) ] Institute of Cancer Research, Sutton, Surrey, UK
                [(8) ] Department of Haematology, University of Cambridge, UK
                Author notes
                Address for correspondence: Drs Andy Futreal, Mike Stratton and Peter Campbell, Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, United Kingdom. Tel: +44 (0) 1223 834244 Fax: +44 (0) 1223 494809 paf@ 123456sanger.ac.uk , mrs@ 123456sanger.ac.uk , pc8@ 123456sanger.ac.uk
                Article
                UKMS28042
                10.1038/nature08629
                2880489
                20016488
                d36a824c-e83d-4914-88b0-1e2047d34b9b

                Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Funding
                Funded by: Wellcome Trust :
                Award ID: 093867 || WT
                Funded by: Wellcome Trust :
                Award ID: 088340 || WT
                Funded by: Wellcome Trust :
                Award ID: 077012 || WT
                Categories
                Article

                Uncategorized
                Uncategorized

                Comments

                Comment on this article